Healthcare provider profile · identity verified

Sheetal Aatrai, MD

Internal Medicine · MARSHFIELD, WI · NPI 1417568965

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	318	123
Levothyroxine Sodium	Levothyroxine Sodium	287	84
Amlodipine Besylate	Amlodipine Besylate	202	74
Lisinopril	Lisinopril	171	59
Hydrochlorothiazide	Hydrochlorothiazide	141	52
Omeprazole	Omeprazole	122	46
Gabapentin	Gabapentin	120	36
Losartan Potassium	Losartan Potassium	116	43
Metoprolol Succinate	Metoprolol Succinate	112	45
Alendronate Sodium	Alendronate Sodium	102	38
Ozempic	Semaglutide	100	15
Metoprolol Tartrate	Metoprolol Tartrate	82	24
Simvastatin	Simvastatin	82	29
Albuterol Sulfate Hfa	Albuterol Sulfate	68	35
Potassium Chloride	Potassium Chloride	65	21
Rosuvastatin Calcium	Rosuvastatin Calcium	62	24
Sertraline Hcl	Sertraline Hcl	59	25
Furosemide	Furosemide	58	28
Pravastatin Sodium	Pravastatin Sodium	57	20
Metformin Hcl	Metformin Hcl	56	26
Warfarin Sodium	Warfarin Sodium	52	23
Pantoprazole Sodium	Pantoprazole Sodium	48	20
Tramadol Hcl	Tramadol Hcl	46	16
Allopurinol	Allopurinol	45	14
Fluticasone Propionate	Fluticasone Propionate	41	19
Fluoxetine Hcl	Fluoxetine Hcl	39	14
Clopidogrel	Clopidogrel Bisulfate	37	12
Metformin Hcl Er	Metformin Hcl	32	12
Alprazolam	Alprazolam	31	12
Ezetimibe	Ezetimibe	30	14
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Enalapril Maleate	Enalapril Maleate	27	12
Tamsulosin Hcl	Tamsulosin Hcl	27	suppressed
Carvedilol	Carvedilol	26	11
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Eliquis	Apixaban	26	14
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Amoxicillin	Amoxicillin	25	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Lovastatin	Lovastatin	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Naproxen	Naproxen	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Atenolol	Atenolol	19	suppressed
Estradiol	Estradiol	19	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	18	18
Famotidine	Famotidine	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Nitroglycerin	Nitroglycerin	16	15
Trazodone Hcl	Trazodone Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Azithromycin	Azithromycin	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Glipizide	Glipizide	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Topiramate	Topiramate	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	12
Valacyclovir	Valacyclovir Hcl	13	suppressed
Nystatin	Nystatin	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Baclofen	Baclofen	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error